Skip to main content

Table 3 Comparison of group B children with mucosal healing (Marsh < 2) and mucosal injury (Marsh ≥ 2)

From: Follow-up of pediatric celiac disease: value of antibodies in predicting mucosal healing, a prospective cohort study

 

Marsh < 2

Marsh ≥ 2

P

 

(n = 47)

(n = 6)

 

Serology [n (%)]

   

Negativity of all antibody tests (anti-tissue transglutaminase IgA and -IgG, anti-deamidated-gliadin-peptide IgA and -IgG, anti-endomysial antibodies IgA)

22 (46.8)

0

0.035

Positivity of at least one antibody test

25 (53.1)

6 (100)

 

Chief complaint [n (%)]

   

Asymptomatic

38 (80.9)

4 (66.7)

0.592

Intestinal symptoms

9 (19.1)

1 (16.7)

1.000

Extraintestinal symptoms

0

1 (16.7)

0.113

Weight-for-age z score, mean ± standard deviation

−0.66 ± 1.31

−1.04 ± 2.03

0.529

Height-for-age z score, mean ± standard deviation

−0.63 ± 1.21

−1.58 ± 1.74

0.094